PharmSci Today #9
In episode 09 of the PharmSci Today podcast, Paul Bennett (CEO, RPS), Prof Gino Martini (RPS Chief Scientist) and Sarah Cahill (Clinical Fellow, RPS) talk to Richard Saynor (CEO, Sandoz).
Richard discusses Sandoz’s response to COVID-19 and how they are maintaining supply chains and supporting clinical trials to combat the coronavirus. Sandoz is one of the largest suppliers of generic medicines in the world and a separate division of Novartis.
Gino talks to Dr Hubert Bland from pharmaceutical company Sanofi, discussing the prospects for coronavirus treatments and vaccines.
In this podcast, Sanofi will talk about experimental vaccines and a few existing medicines that are approved for other indications. Sanofi wants to be very clear that use of any of its medicines in COVID-19 is off-label, entirely experimental at this stage – therefore unproven. Sanofi wants to caution they are not endorsing use of these medicines. Their intent is to explain to the society’s listeners the current status of these studies.